Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 72.78B P/E 85.80 EPS this Y 9.80% Ern Qtrly Grth 260.00%
Income 1.57B Forward P/E 22.60 EPS next Y 13.30% 50D Avg Chg -4.00%
Sales 14.24B PEG 2.46 EPS past 5Y 11.73% 200D Avg Chg 5.00%
Dividend N/A Price/Book 4.08 EPS next 5Y 12.28% 52W High Chg -8.00%
Recommedations 1.70 Quick Ratio 0.63 Shares Outstanding 1.47B 52W Low Chg 34.00%
Insider Own 0.20% ROA 4.47% Shares Float 1.46B Beta 0.78
Inst Own 93.69% ROE 8.58% Shares Shorted/Prior 11.48M/11.03M Price 50.62
Gross Margin 69.16% Profit Margin 11.18% Avg. Volume 7,694,100 Target Price 71.96
Oper. Margin 16.56% Earnings Date Apr 24 Volume 7,777,369 Change -2.45%
About Boston Scientific Corporation

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX Chatroom

User Image ElliottwaveForecast Posted - 8 hours ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image ElliottwaveForecast Posted - 1 day ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image Ro_Patel Posted - 1 day ago

$SWAV jumped yesterday over rumours of a buyout from $JNJ - WSJ also reported that other offers may be forthcoming Shockwave makes devices to treat heart disease (uses shockwaves to break down calcified plaque in heart vessels) & has a market cap of around $11.78B The company guided FY24 Revs of $910M-$930M [up +25 to +27% y/y] Last year, it was rumoured that $BSX was kicking the tires In 2022, J&J acquired heart pump maker Abiomed for $16.6B - Abiomed was a onetime investor in Shockwave. Last year split off of consumer health business $KVUE has given J&J some ammo to expand further into devices & pharma investment.

User Image DonCorleone77 Posted - 2 days ago

$SWAV $JNJ $MDT $BSX Piper says competitive process could materialize for ShockWave Piper Sandler analyst Adam Maeder says the Wall Street Journal's report of potential takeover interest reaffirms the view that ShockWave Medical (SWAV) is an "excellent strategic asset that would fit well within a larger company." The firm also believes ShockWave is well positioned for continued success as a standalone entity. Piper thinks a potential acquisition by Johnson & Johnson (JNJ) has some strategic merit. However, it believes any acquirer would need to pay a sizable takeout multiple to consummate a deal. Piper views Medtronic (MDT) and Boston Scientific (BSX) as more natural strategic fits than Johnson & Johnson for ShockWave given the companies' existing broad focus in interventional cardiology and peripheral vascular. As such, the firm would not be surprised to see a competitive process materialize for ShockWave.

User Image TraderJackson_ Posted - 2 days ago

TTNP Top Squeeze Watch! Keep it on watch for another high volume spike to 12+ $CTSH $ADT $BSX $HL ©

User Image ElliottwaveForecast Posted - 2 days ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image xMonti Posted - 2 days ago

$NARI after loosing Shockwave $SWAV ! Boston $BSX can go to Inari for xxx value

User Image HammerstoneMarkets Posted - 2 days ago

$BSX +10.50% after @wsj reports $JNJ in talks to acquire the company. --- $BSX moves +1.23% as the rumored suitor from last April trades higher as investors are relieved the Boston Scientific won't be attempting a very expensive take-over of Shockwave -$SWAV shares are +851% over the past 5-years ---- -ICYMI $PFE shrs are +15c

User Image DonCorleone77 Posted - 3 days ago

$BSX Boston Scientific, Scivita Medical expand strategic cooperation arrangement Scivita Medical and Boston Scientific joined hands again to sign an expanded strategic cooperation arrangement. The introduction of iterative endoscopic technology has brought about a positive transformation in the field of endoscopy, making it an interventional tool that combines diagnosis and treatment. Under the arrangement, Scivita Medical will expand its relationship with Boston Scientific for strategic co-development and global distribution activities. Such activities may include collaboration on the co-development of future endoscopic devices, and global distribution opportunities for Scivita Medical's single-use endoscope and imaging devices. It is expected that this expanded arrangement will help bring Scivita Medical products to more hospitals and patients throughout China and other global geographies.

User Image Stock_Titan Posted - 3 days ago

$BSX Scivita Medical Expands Collaboration with Boston Scientific https://www.stocktitan.net/news/BSX/scivita-medical-expands-collaboration-with-boston-b7idcxubipb4.html

User Image ChartMill Posted - 3 days ago

$BSX - tight price range in uptrend

User Image StockConsultant Posted - 3 days ago

$BSX Boston Scientific stock narrow range breakout watch

User Image ElliottwaveForecast Posted - 4 days ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image Corsefire11 Posted - 5 days ago

$AERO.X $BSX Treating me well ❤️

User Image DonCorleone77 Posted - 6 days ago

$AXNX $BSX Axonics shareholders approve merger with Boston Scientific Axonics (AXNX) announced that its stockholders have voted to adopt Axonics' merger agreement with Boston Scientific (BSX). The closing of the transaction is expected to occur in the first half of 2024 and remains subject to certain conditions, including receipt of approvals or clearances, or the expiration, termination or waiver of applicable waiting periods under U.S. and foreign antitrust laws.

User Image lecorb Posted - 6 days ago

$BSX https://seekingalpha.com/news/4083035-axonics-shareholders-approve-merger-with-boston-sci?mailingid=34788637&messageid=2900&serial=34788637.3062&utm_campaign=rta-stock-news&utm_content=link-3&utm_medium=email&utm_source=seeking_alpha&utm_term=34788637.3062

User Image Stock_Titan Posted - 6 days ago

$AXNX $BSX Axonics Stockholders Approve Merger Agreement with Boston Scientific https://www.stocktitan.net/news/AXNX/axonics-stockholders-approve-merger-agreement-with-boston-ps1hiyxbm0bb.html

User Image Mergerbrief Posted - 1 week ago

$AXNX $BSX - $AXNX Shareholder Vote mergerbrief.com

User Image RedBear Posted - 1 week ago

$BSX only ride breakout winners

User Image ca_rott1487 Posted - 1 week ago

$BSX settles $38.5M with investors to end claims over the promoted heart valve product, later withdrawn from the market. Claim submission info and details:https://11thestate.com/cases/boston-scientific-shareholder-settlement

User Image ElliottwaveForecast Posted - 1 week ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image ElliottwaveForecast Posted - 1 week ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image ElliottwaveForecast Posted - 1 week ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image Nosh Posted - 1 week ago

$BSX If this would do a re-test of previous resistance now support...I would come in there...

User Image tkathlina Posted - 1 week ago

$BSX $BSX strong buy 💪

User Image ElliottwaveForecast Posted - 1 week ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image tkathlina Posted - 1 week ago

$BSX $BSX Bulls making a run 🏃‍♀️ for breakout

User Image Shortslie Posted - 1 week ago

$BSGM today was actually the best news $BSGM could have gotten of the two alternatives. Decline of a hearing and instant delisting or a hearing date in May giving the company time to come up with a plan. 1 that appears to have started with the 500k reasonable loan with interest and principal due not until 2026 with no equity or warrants given. Sure seems like large investor helping them to continue. Remember Fred H moved to US in November full time talking to his old colleagues at $BSX $MDT $ABT $JNJ - he is very wealthy and doesn’t need this mess. Why come back after you resigned your board spot and then when CEO resigned and take this role of President and Board member on unless you had some positive discussions since Nov. now has until May 7. The loan is a big positive tell imo. https://www.biosig.com/news-media/press-releases/detail/349/biosig-appoints-global-medtech-leader-fred-hrkac-as-new

User Image ElliottwaveForecast Posted - 1 week ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

User Image ElliottwaveForecast Posted - 1 week ago

$BSX Boston Scientific Corporation (BSX) Should Continue Uptrend & Remain Supported : https://elliottwave-forecast.com/stock-market/boston-scientific-corporation-bsx-should-continue-uptrend-remain-supported/ #Elliottwave #Trading #Stock

Analyst Ratings
TD Cowen Outperform Mar 7, 24
RBC Capital Outperform Feb 5, 24
Citigroup Buy Feb 1, 24
Oppenheimer Perform Feb 1, 24
Mizuho Buy Feb 1, 24
RBC Capital Outperform Feb 1, 24
JP Morgan Overweight Feb 1, 24
Raymond James Strong Buy Feb 1, 24
Wells Fargo Overweight Feb 1, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Mirviss Jeffrey B. EVP&Pres, Periph Int.. EVP&Pres, Periph Intervent Jan 09 Sell 59.25 15,172 898,941 56,588 01/10/24
Mirviss Jeffrey B. EVP&Pres, Periph Int.. EVP&Pres, Periph Intervent Jan 09 Option 16.31 15,172 247,455 71,760 01/10/24
Mirviss Jeffrey B. EVP&Pres, Periph Int.. EVP&Pres, Periph Intervent Jan 04 Sell 58.4 15,000 876,000 56,588 01/05/24
Mirviss Jeffrey B. EVP&Pres, Periph Int.. EVP&Pres, Periph Intervent Jan 04 Option 16.31 15,000 244,650 71,588 01/05/24
Fitzgerald Joseph Michael EVP & Group Pres, Ca.. EVP & Group Pres, Cardiology Dec 29 Sell 57.5 81,940 4,711,550 174,241 01/02/24
Fitzgerald Joseph Michael EVP & Group Pres, Ca.. EVP & Group Pres, Cardiology Dec 29 Option 8.16 79,988 652,702 196,040 01/02/24
Mahoney Michael F Chairman, President.. Chairman, President & CEO Oct 09 Sell 52.09 113,355 5,904,662 1,498,922 10/10/23
Mahoney Michael F Chairman, President.. Chairman, President & CEO Oct 09 Option 14.7 113,355 1,666,318 1,612,277 10/10/23
Carruthers Wendy EVP, Human Resources EVP, Human Resources Sep 15 Sell 53.95 11,671 629,650 57,058 09/15/23
Carruthers Wendy EVP, Human Resources EVP, Human Resources Sep 15 Option 14.7 6,408 94,198 68,729 09/15/23
Mahoney Michael F Chairman, President.. Chairman, President & CEO Sep 12 Option 14.7 113,355 1,666,318 1,612,277 09/12/23
Mahoney Michael F Chairman, President.. Chairman, President & CEO Sep 12 Sell 53.91 113,355 6,110,968 1,498,922 09/12/23
Butcher Arthur C EVP& Grp Pres, MedSu.. EVP& Grp Pres, MedSurg & APAC Aug 21 Sell 50.4032 6,600 332,661 11,396 08/22/23
Carruthers Wendy EVP, Human Resources EVP, Human Resources Jul 17 Sell 52.85 11,671 616,812 67,584 07/18/23
Carruthers Wendy EVP, Human Resources EVP, Human Resources Jul 17 Option 14.7 6,408 94,198 79,255 07/18/23
Thepaut Eric Francis Yves EVP & Pres, Eur, Mid.. EVP & Pres, Eur, Mid-East, Afr May 02 Sell 52.49 83,401 4,377,718 12,269 05/03/23
Thepaut Eric Francis Yves EVP & Pres, Eur, Mid.. EVP & Pres, Eur, Mid-East, Afr May 02 Option 12.89 30,688 395,568 95,670 05/03/23
Brennan Daniel J. EVP and CFO EVP and CFO Feb 15 Sell 47.14 7,572 356,944 276,316 02/16/23
Brennan Daniel J. EVP and CFO EVP and CFO Feb 15 Option 3.7 11,725 43,382 285,107 02/16/23
Butcher Arthur C EVP& Grp Pres, MedSu.. EVP& Grp Pres, MedSurg & APAC Feb 03 Sell 48.74 27,000 1,315,980 23,392 02/06/23
Butcher Arthur C EVP& Grp Pres, MedSu.. EVP& Grp Pres, MedSurg & APAC Feb 03 Option 16.79 15,034 252,421 50,392 02/06/23
Carruthers Wendy EVP, Human Resources EVP, Human Resources Dec 15 Sell 46.6224 7,500 349,668 87,413 12/15/22
Mirviss Jeffrey B. EVP&Pres, Periph Int.. EVP&Pres, Periph Intervent Dec 12 Sell 46.7500 11,080 517,990 88,479 12/13/22
Thepaut Eric Francis Yves EVP & Pres, Eur, Mid.. EVP & Pres, Eur, Mid-East, Afr Nov 18 Sell 42.7216 14,952 638,773 57,534 11/21/22
Mahoney Michael F Chairman, President.. Chairman, President & CEO Nov 07 Option 10.24 125,827 1,288,468 1,893,492 11/08/22
Mahoney Michael F Chairman, President.. Chairman, President & CEO Nov 07 Sell 41.97 125,827 5,280,959 1,767,665 11/08/22
Carruthers Wendy EVP, Human Resources EVP, Human Resources Aug 15 Sell 42.0346 7,500 315,260 117,413 08/15/22
Mahoney Michael F Chairman, President.. Chairman, President & CEO Aug 08 Option 10.24 125,828 1,288,479 2,258,950 08/09/22
Mahoney Michael F Chairman, President.. Chairman, President & CEO Aug 08 Sell 40.97 125,828 5,155,173 2,133,122 08/09/22
Connors Nelda J Director Director Aug 02 Sell 41.5800 16,088 668,939 4,877 08/04/22
Thepaut Eric Francis Yves EVP & Pres, Eur, Mid.. EVP & Pres, Eur, Mid-East, Afr Aug 01 Sell 40.9900 20,676 847,509 72,486 08/03/22
Carruthers Wendy EVP, Human Resources EVP, Human Resources Jul 18 Sell 38.0000 7,500 285,000 124,913 07/18/22
Carruthers Wendy EVP, Human Resources EVP, Human Resources Jun 24 Sell 38.0000 7,500 285,000 132,413 06/27/22
Mirviss Jeffrey B. EVP&Pres, Periph Int.. EVP&Pres, Periph Intervent Apr 19 Sell 45.5000 10,989 500,000 119,961 04/20/22
Carruthers Wendy EVP, Human Resources EVP, Human Resources Apr 14 Sell 44.4691 7,500 333,518 147,413 04/14/22
Butcher Arthur C EVP&Pres, Asia Pacif.. EVP&Pres, Asia Pacific Mar 29 Option 16.31 5,411 88,253 40,547 03/31/22
Butcher Arthur C EVP&Pres, Asia Pacif.. EVP&Pres, Asia Pacific Mar 29 Sell 45 10,269 462,105 30,278 03/31/22
Meredith Ian T EVP Global Chief Med.. EVP Global Chief Med Officer Mar 28 Sell 43.6800 6,588 287,764 28,082 03/29/22
Pierce David A EVP Pres MedSurg EVP Pres MedSurg Feb 15 Option 0 2,769 2,769 02/17/22
Pierce David A EVP Pres MedSurg EVP Pres MedSurg Feb 15 Sell 43.81 1,956 85,692 02/17/22
Brennan Daniel J. EVP and CFO EVP and CFO Feb 15 Option 3.14 16,340 51,308 278,364 02/17/22
Brennan Daniel J. EVP and CFO EVP and CFO Feb 15 Sell 43.59 21,323 929,470 266,177 02/17/22
Mahoney Michael F Chairman, President.. Chairman, President & CEO Sep 08 Sell 44.57 201,041 8,960,397 2,081,822 09/08/21
Mahoney Michael F Chairman, President.. Chairman, President & CEO Sep 08 Option 6.84 201,041 1,375,120 2,282,863 09/08/21